Search - tctmd.com

Displaying 141 - 160 of 238

Sort: Relevancy | Date

News Conference News HRS 2019

BeAT-HF: Baroreflex Activation Therapy Improves Outcomes in Subset of HF Patients

Todd Neale

May 15, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Conference News ACC 2019

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Michael O'Riordan

March 25, 2019

News Conference News ACC 2019

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

Shelley Wood

March 22, 2019

Presentation ACC 2019

A Fully Magnetically Levitated Left Ventricular Assist Device: Final Report of the MOMENTUM 3 Trial

Presenter: Mandeep R. Mehra

March 19, 2019

News Conference News ACC 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

Shelley Wood

March 17, 2019

Manuscript

TAVR in Patients with Left Ventricular Assist Device: Case Report and Literature Review

December 21, 2018

News Conference News AHA 2018

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

Yael L. Maxwell

November 12, 2018

News Conference News AHA 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Michael O'Riordan

November 11, 2018

News Daily News

Bradycardia Guidelines Offer Tips on Diagnosis, Management

Caitlin E. Cox

November 08, 2018

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

L.A. McKeown

November 02, 2018

News Daily News

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

Michael O'Riordan

October 19, 2018

Presentation TCT 2018

SHIELD II: Acute Outcomes and 90-Day Results in Patients Undergoing High-Risk PCI Supported With a Percutaneous Left Ventricular Assist Device

Presenter: Jonathan M. Hill, E. Magnus Ohman, David E. Kandzari

September 22, 2018

Presentation TCT 2018

AMICS: Predictors of Survival in Patients With Acute Myocardial Infarction and Cardiogenic Shock Supported With a Percutaneous Left Ventricular Assist Device

Presenter: Jonathan M. Hill, E. Magnus Ohman, William W. O'Neill

September 22, 2018

News Conference News PCR London Valves 2018

Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications

Shelley Wood

September 10, 2018

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Caitlin E. Cox

July 30, 2018

News Daily News

Class I Recall for Medtronic’s HeartWare HVAD System

Michael O'Riordan

June 04, 2018

News Daily News

HeartMate 3 Problem With Outflow Graft Twisting Called Class I Recall by FDA

Todd Neale

May 23, 2018

News Industry News

Abott Implements Corrective Action for Heartmate 3 Heart Pump

May 07, 2018

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Caitlin E. Cox

May 02, 2018

Advertisement

BeAT-HF: Baroreflex Activation Therapy Improves Outcomes in Subset of HF Patients

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

A Fully Magnetically Levitated Left Ventricular Assist Device: Final Report of the MOMENTUM 3 Trial

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

TAVR in Patients with Left Ventricular Assist Device: Case Report and Literature Review

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Bradycardia Guidelines Offer Tips on Diagnosis, Management

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

SHIELD II: Acute Outcomes and 90-Day Results in Patients Undergoing High-Risk PCI Supported With a Percutaneous Left Ventricular Assist Device

AMICS: Predictors of Survival in Patients With Acute Myocardial Infarction and Cardiogenic Shock Supported With a Percutaneous Left Ventricular Assist Device

Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Class I Recall for Medtronic’s HeartWare HVAD System

HeartMate 3 Problem With Outflow Graft Twisting Called Class I Recall by FDA

Abott Implements Corrective Action for Heartmate 3 Heart Pump

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content